Seascape Capital Management reduced its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,266 shares of the company’s stock after selling 203 shares during the period. AbbVie makes up 1.7% of Seascape Capital […]
Seascape Capital Management trimmed its stake in Booking Holdings Inc. (NASDAQ:BKNG – Free Report) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 971 shares of the business services provider’s stock after selling 20 shares during the period. Seascape Capital Management’s […]
Seascape Capital Management cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,259 shares of the company’s stock after selling 1,357 shares during the quarter. AstraZeneca comprises approximately […]
Seascape Capital Management trimmed its position in shares of Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 19,008 shares of the semiconductor company’s stock after selling 111 shares during the quarter. Texas Instruments comprises about 1.6% of […]
Seascape Capital Management grew its position in Williams-Sonoma, Inc. (NYSE:WSM – Free Report) by 0.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,466 shares of the specialty retailer’s stock after buying an additional 87 shares during the quarter. Williams-Sonoma accounts for about […]